Retinal atrophy in osteopetrosis.
D002128:Calcium Metabolism Disorders; D002136:Calcium, Dietary; D003023:Cloxacillin / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006821:Hyaluronoglucosaminidase / Q000627:therapeutic use; D007223:Infant; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases; D008661:Metabolism, Inborn Errors; D009896:Optic Atrophy / Q000150:complications* / Q000473:pathology; D009900:Optic Nerve / Q000473:pathology; D010022:Osteopetrosis / Q000150:complications / Q000151:congenital* / Q000473:pathology; D010406:Penicillins / Q000627:therapeutic use; D010786:Photoreceptor Cells / Q000002:abnormalities; D011239:Prednisolone / Q000627:therapeutic use; D012160:Retina / Q000002:abnormalities* / Q000473:pathology; D013194:Staining and Labeling; D013418:Sulfamethazine / Q000627:therapeutic use
D002136:Calcium, Dietary; D010406:Penicillins; D013418:Sulfamethazine; D011239:Prednisolone; D006821:Hyaluronoglucosaminidase; D003023:Cloxacillin